Scott J. Rodig

2 Patents

• US117239722023

  Compositions, Kits, and Methods for the Diagnosis, Prognosis, Monitoring, Treatment and Modulation of Post-transplant Lymphoproliferative Disorders and Hypoxia Associated Angiogenesis Disorders Using Galectin-1

  Fundacion Sales

  0 cites
• US116739562023

  Anti-galectin-1 (gal1) Monoclonal Antibodies and Fragments Thereof for Neutralizing Gal1

  Dana-farber Cancer Institute, Inc.

  0 cites